Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of γλ T cells

British Journal of Dermatology

Volumn 166, Issue 1, 2012, Pages 216-218

  Tanaka, C ^a   Hasegawa, M ^a   Fujimoto, M ^a   Iwatsuki, K ^b   Yamamoto, T ^b   Yamada, K ^c   Kawa, K ^c   Saikawa, Y ^d   Toga, A ^a   Mase, S ^a   Wada, T ^a   Takehara, K ^a   Yachie, A ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^d KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE; VIRUS DNA;

ANTIBODY TITER; APHTHOUS STOMATITIS; BLOOD CELL COUNT; CASE REPORT; CHILD; CHRONIC ACTIVE EPSTEIN BARR VIRUS DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HUMAN; HUMAN TISSUE; HYDROA VACCINIFORME; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LETTER; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; PAPULOVESICULAR RASH; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN DEFECT; SUN EXPOSURE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THROMBOCYTE COUNT;

CHILD, PRESCHOOL; CHRONIC DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; HYDROA VACCINIFORME; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISORDERS; T-LYMPHOCYTE SUBSETS;

EID: 84555190476     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10512.x     Document Type: Letter

References (8)

1. Kasahara Y, Yachie A, Takei K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001; 98: 1882-8.
2. Yamamoto T, Tsuji K, Suzuki D, et al. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts. J Microbiol Methods 2007; 68: 403-7. (Pubitemid 46149956)
3. Wada T, Yokoyama T, Nakagawa H, et al. Flow cytometric analysis of skin blister fluid induced by mosquito bites in a patient with chronic active Epstein-Barr virus infection. Int J Hematol 2009; 90: 611-15.
4. Cohen JI, Jaffe ES, Dale JK, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 2011; 117: 5835-49.
5. Quintanilla-Martinez L, Kimura H, Jaffe E,. EBV-positive T-cell lymphoproliferative disorders of childhood. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (, Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, et al., eds), 4th edn. Lyon: IARC Press, 2008; 278-80.
6. Koyama M, Takeshita Y, Sakata A, et al. Cytotoxic chemotherapy successfully induces durable complete remission in 2 patients with mosquito allergy resulting from Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative disease. Int J Hematol 2005; 82: 437-40. (Pubitemid 46638694)
7. Kimura H, Miyake K, Yamauchi Y, et al. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. J Infect Dis 2009; 200: 1078-87.
8. Iwatsuki K, Satoh M, Yamamoto T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006; 142: 587-95. (Pubitemid 43727549)